Potassium channel opener with anti anginal activity is
**Core Concept:** Potassium channels are integral membrane proteins that regulate the movement of potassium ions across the cell membrane, playing a crucial role in maintaining resting membrane potential, action potential, and cell excitability. Anti-anginal medications help relieve chest pain caused by angina pectoris, a condition where insufficient blood supply to the heart muscle leads to reduced oxygen delivery, triggering pain in response to increased demand.
**Why the Correct Answer is Right:** Nitrates are a class of drugs that exert their effects by opening potassium channels, leading to hyperpolarization of cardiac myocytes and relaxation of vascular smooth muscle. This results in decreased myocardial oxygen demand, increased coronary blood flow, and reduced angina symptoms.
**Why Each Wrong Option is Incorrect:**
A. **Option A (Nifedipine):** Nifedipine is a calcium channel blocker, not a potassium channel opener. Calcium channel blockers reduce myocardial oxygen demand by inhibiting calcium entry into cardiac and vascular smooth muscle cells, leading to vasodilation and decreased cardiac contractility.
B. **Option B (Aspirin):** Although aspirin inhibits platelet aggregation, it is not a potassium channel opener or anti-anginal agent. Aspirin primarily acts as an antiplatelet agent, reducing the risk of atherothrombotic complications in coronary artery disease.
C. **Option C (Amlodipine):** Similar to nifedipine, amlodipine is a calcium channel blocker. It does not open potassium channels or provide anti-anginal relief through this mechanism.
D. **Option D (Ibutilide):** Ibutilide is a class III antiarrhythmic agent, targeting voltage-gated sodium channels, not potassium channels or providing anti-anginal relief. Its primary use is in the treatment of atrial fibrillation.
**Clinical Pearl:** Nitrates, specifically isosorbide derivatives (e.g., isosorbide dinitrate, isosorbide mononitrate), are potent anti-anginal agents targeting potassium channels, with a significant impact on reducing myocardial oxygen demand and improving angina symptoms. This is crucial for medical students and practitioners to understand the distinction between various drug classes and their specific mechanisms of action in cardiovascular diseases.